Burn Study- Tranexamic Acid Versus Thrombin in Split Thickness Skin Graft

PHASE4RecruitingINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

July 11, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
BurnsSkin Graft Complications
Interventions
DRUG

Tranexamic acid

100mg/mL 10mL vials x2 of injectable tranexamic acid will be filled into a 20 milliliter syringe with a spray tip.

DRUG

Thrombin JMI

The wound base is then sprayed with a film of Thrombin-JMI

PROCEDURE

skin graft

Skin is taken from uninjured part of the participant's body and used to surgically cover a wound or injured area with skin that contains the epidermis and a portion of the dermis.

Trial Locations (1)

66160

RECRUITING

The University of Kansas Health System, Kansas City

All Listed Sponsors
lead

University of Kansas Medical Center

OTHER